Clara Vásquez VelásquezGraciela RussomandoEmilio E. EspínolaZunilda SánchezKota MochizukiYelin RocaJimmy RevolloAngelica GuzmanBenjamín QuirogaSusana Rios Morgan2026-03-222026-03-22201910.1371/journal.pntd.0007715https://doi.org/10.1371/journal.pntd.0007715https://andeanlibrary.org/handle/123456789/49081Citaciones: 8Plasma levels of IL-17A might be a bio-marker for detecting persistent infection of T. cruzi and its chronic inflammation.enTrypanosoma cruziBiomarkerNeglected tropical diseasesChagas diseaseBiologyImmunologyVirologyMedicineEnvironmental healthIL-17A, a possible biomarker for the evaluation of treatment response in Trypanosoma cruzi infected children: A 12-months follow-up study in Boliviaarticle